ADXS11-001 High Dose HPV+ Cervical Cancer

This is an interventional treatment trial for Effects of Immunotherapy focused on measuring Adenocarcinoma, Carcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Small Cell Lung Carcinoma, Carcinoma, Small Cell, Carcinoma, Adenosquamous, Neoplasms, Glandular and Epithelial, Neoplasms by Histologic Type, Neoplasms, Neoplasms, Squamous Cell, Uterine Neoplasms, Genital Neoplasms, Female, Urogenital Neoplasms, Neoplasms by Site, Uterine Cervical Diseases, Uterine Diseases, Genital Diseases, Female Read More

Inclusion Criteria:

• Patients with histologically-confirmed, persistent, metastatic or recurrent squamous or non-squamous cell carcinoma, adenosquamous carcinoma, or adenocarcinoma of the cervix with documented disease progression (disease not amenable to surgery or standard radiotherapy).
• Patients who have received no more than 1 prior cytotoxic treatment regimen.
• Subject may have received ≤2 prior regimens for the treatment of their metastatic disease.
• Subject is able to provide written informed consent.
• Subject must have an ECOG performance status of 0 or 1.

Exclusion Criteria:

• In the opinion of the investigator, subject has rapidly progressing disease, OR has life expectancy of less than 6 months, OR would be unable to receive at least one cycle of therapy.
• Subject has received chemotherapy and/or radiation therapy (except palliative radiation therapy for disease-related pain) within ≤2 weeks of first ADXS11-001 infusion.
• Subject has a known additional malignancy that is progressing or requires active treatment. Exceptions include basal cell carcinoma of the skin, squamous cell carcinoma of the skin, or in situ cervical cancer that has undergone potentially curative therapy.
• Has a contraindication to administration of trimethoprim/sulfamethoxazole or ampicillin.
• Has implanted medical device(s) that pose a high risk for colonization and/or cannot be easily removed (e.g., prosthetic joints, artificial heart valves, pacemakers, orthopedic screw(s), metal plate(s), bone graft(s), or other exogenous implant(s)). NOTE: More common devices and prosthetics which include arterial and venous stents, dental and breast implants, and venous access devices (e.g., Port-a-Cath or Mediport) are permitted. Sponsor must be contacted prior to consenting any subject who has any other device and/or implant.